Evidence map›Paper›PMID 37570885›Full record

ReviewMolecules (Basel, Switzerland)2023

Bioactive Metabolites from Terrestrial and Marine Actinomycetes.

Chananan Ngamcharungchit, Nutsuda Chaimusik, Watanalai Panbangred, Jirayut Euanorasetr, Bungonsiri Intra

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Diabetes-associatedMicrobiology spectrum · 2026
    Observational
  2. Article
  3. Aquatic-derived Streptomyces cavourensis BA1 as a promising source of antibacterial metabolites against multidrug-resistant gram-negative pathogens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chananan NgamcharungchitDepartment of Biotechnology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0009-0000-3989-1355
Nutsuda ChaimusikDepartment of Biotechnology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0009-0009-1818-1755
Watanalai PanbangredResearch, Innovation and Partnerships Office, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0000-0003-0141-9279
Jirayut EuanorasetrDepartment of Microbiology, Faculty of Science, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0000-0003-2300-797X
Bungonsiri IntraDepartment of Biotechnology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0002-8408-4197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinomycetes inhabit both terrestrial and marine ecosystems and are highly proficient in producing a wide range of natural products with diverse biological functions, including antitumor, immunosuppressive, antimicrobial, and antiviral activities. In this review, we delve into the life cycle, ecology, taxonomy, and classification of actinomycetes, as well as their varied bioactive metabolites recently discovered between 2015 and 2023. Additionally, we explore promising strategies to unveil and investigate new bioactive metabolites, encompassing genome mining, activation of silent genes through signal molecules, and co-cultivation approaches. By presenting this comprehensive and up-to-date review, we hope to offer a potential solution to uncover novel bioactive compounds with essential activities.

Indexed as

ActinobacteriaAnti-Infective AgentsBiological ProductsActinomycesEcosystemAnti-Infective AgentsBiological Productsactinomycetesbioactive metabolitesbiodiversitygenome miningsilent gene activation

Identifiers

PMID37570885
PMCPMC10421486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.